-+ 0.00%
-+ 0.00%
-+ 0.00%

Skye Bioscience Q4 EPS $(0.36) Misses $(0.30) Estimate

Benzinga·03/10/2026 20:02:13
Listen to the news
Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.30) by 21.21 percent. This is a 50 percent decrease over losses of $(0.24) per share from the same period last year.